Stocks
ABIOMED (ABMD) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.20 | -2.13 | 23.7 | 55.9 | 28.6 | 35.1 | ||
| Changes by years, y/y, % | -104% | -3% | -1 215% | +135% | -49% | -12.2% | |||
ABIOMED. EV/EBITDA
ABIOMED. EV/EBITDA, changes, %
ABIOMED (ABMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| EV/EBITDA | ? | 35.5 | 39.8 | 34.3 | 33.7 | 22.0 | 35.1 | |
| Changes by years, y/y, % | -30% | -33% | -39% | -2% | -38% | |||
| Changes by quarters, q/q, % | +3% | +12% | -14% | -2% | -35% | |||
